TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17212893

Group type: EXPERIMENTAL
Intervention: Local anesthesia (0.25% bupivacaine with epinephrine) infiltrated into abdominal wall wounds at suture fixation sites
Number of subjects: 18

Group type: COMPARATOR
Intervention: No local anesthesia (control group)
Number of subjects: 18
Study: 12704485

Group type: EXPERIMENTAL
Intervention: Pharmacist services (intervention group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care from clinic staff (nonintervention group)
Number of subjects: 80
Study: 10585345

Group type: EXPERIMENTAL
Intervention: Latex method for hs-CRP measurement
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: ELISA method for hs-CRP measurement
Number of subjects: 288
Study: 8915969

Group type: EXPERIMENTAL
Intervention: Dietary protein restriction
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Strict blood pressure control (mean arterial pressure reduction)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Starting treatment with diuretics
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Starting treatment with beta-blockers
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Starting treatment with angiotensin-converting enzyme inhibitors
Number of subjects: 840
Study: 1918302

Group type: EXPERIMENTAL
Intervention: Growth hormone (Norditropin, Novo Nordisk Gentofte A/S) 24 IU intramuscular injections on alternate days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6225984

Group type: EXPERIMENTAL
Intervention: spectinomycine 2 g
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: ampicillin + probenecide 3.5 g + 1 g
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: thiamphenicol 2.5 g
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: minocycline 300 mg
Number of subjects: 636
Study: 29177461

Group type: EXPERIMENTAL
Intervention: Randomized clinical trials for evaluating treatments and vaccines during the Ebola epidemic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Improved planning and collaboration among research and humanitarian organizations
Number of subjects: 0
Study: 27009916

Group type: EXPERIMENTAL
Intervention: Sifalimumab 200 mg
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Sifalimumab 600 mg
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Sifalimumab 1200 mg
Number of subjects: 431

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Sifalimumab (all dosages)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Sifalimumab
Number of subjects: 431
Study: 24756514

Group type: EXPERIMENTAL
Intervention: Acetazolamide (up to 4 g/d) with low-sodium weight-reduction diet
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo with low-sodium weight-reduction diet
Number of subjects: 165
Study: 22789509

Group type: EXPERIMENTAL
Intervention: Rotarix (rotavirus vaccine)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Vivotif (typhoid vaccine)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: ACAM2017 (candidate vaccine against ETEC)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: All vaccines
Number of subjects: 101
Study: 20530499

Group type: EXPERIMENTAL
Intervention: Calcium acetate/magnesium carbonate (CaMg)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Sevelamer hydrochloride (HCl)
Number of subjects: 326
Study: 18198169

Group type: EXPERIMENTAL
Intervention: Quarterly Recovery Management Checkups (RMCs)
Number of subjects: 865
Study: 16132334

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy (LA)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Open appendectomy (OA)
Number of subjects: 252
Study: 12749494

Group type: EXPERIMENTAL
Intervention: Permethrin-treated bed nets (ITNs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control areas (lacking ITNs)
Number of subjects: 0
Study: 10521553

Group type: EXPERIMENTAL
Intervention: Post infectious encephalomyelitis patients
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: MRI follow-up
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Overall clinical and MRI pattern
Number of subjects: 11
Study: 8750154

Group type: EXPERIMENTAL
Intervention: 5‐FU 400 mg/m2/d and FA 200 mg/m2/d i.v. on days 1‐5, TP‐5 50 mg s.c. on days 8‐11, and IL‐2 9 MU/m2 s.c. twice daily on days 12‐16
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 5‐FU + FA + TP‐5 + IL‐2
Number of subjects: 45

Group type: COMPARATOR
Intervention: 5‐FU + FA
Number of subjects: 45
Study: 1902657

Group type: EXPERIMENTAL
Intervention: Albumin administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Crystalloid solutions
Number of subjects: 0
Study: 7470682

Group type: EXPERIMENTAL
Intervention: Dry spirometer (DS)
Number of subjects: 28
Study: 6681970

Group type: EXPERIMENTAL
Intervention: Slow-release furosemide (Eutensin) 40 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Furosemide tablets (Lasix) 40 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 6
Study: 31303479

Group type: EXPERIMENTAL
Intervention: Pharmacist-led educational intervention
Number of subjects: 489

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Baseline responses to PATD and BMQ-Specific items
Number of subjects: 489
Study: 29924809

Group type: EXPERIMENTAL
Intervention: Brief Implicit Association Test (BIAT) for implicit motives measurement
Number of subjects: 0
Study: 26507118

Group type: EXPERIMENTAL
Intervention: Visuotemporal cues during walking training
Number of subjects: 32

Group type: COMPARATOR
Intervention: No visuotemporal cues during walking training
Number of subjects: 32
Study: 25349362

Group type: EXPERIMENTAL
Intervention: Tilmicosin at 10 mg/kg BW (TIL)
Number of subjects: 2336

Group type: EXPERIMENTAL
Intervention: Tulathromycin at 2.5 mg/kg BW (TUL)
Number of subjects: 2336

Group type: COMPARATOR
Intervention: No metaphylactic treatment (ND)
Number of subjects: 2336

Group type: EXPERIMENTAL
Intervention: Steers pulled for BRD
Number of subjects: 2336
Study: 22945707

Group type: EXPERIMENTAL
Intervention: MBT technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: ROTH philosophy
Number of subjects: 30
Study: 20298120

Group type: EXPERIMENTAL
Intervention: Combination of antioxidants (single or double dose)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19298018

Group type: EXPERIMENTAL
Intervention: Erythropoietin and tranexamic acid (TA) administered to selected patients in the study group of 133 patients.
Number of subjects: 221

Group type: COMPARATOR
Intervention: No intervention (control group of 82 patients who did not receive TA).
Number of subjects: 221
Study: 15999571

Group type: EXPERIMENTAL
Intervention: Participatory ergonomics intervention (consultant‐guided six‐step approach)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Participatory ergonomics intervention
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 118
Study: 12063869

Group type: EXPERIMENTAL
Intervention: Somatostatin and synthetic analogues (octreotide)
Number of subjects: 0
Study: 11220531

Group type: EXPERIMENTAL
Intervention: Atrioventricular junctional ablation and DDDR mode-switching pacemaker implantation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Pharmacological treatment
Number of subjects: 43
Study: 7854375

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Dapsone
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Aerosolized pentamidine
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Dapsone (50 mg)
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 843
Study: 1776338

Group type: EXPERIMENTAL
Intervention: Molsidomine (2 x 8 mg/d)
Number of subjects: 393

Group type: COMPARATOR
Intervention: ASA (1 x 500 mg/d) plus nifedipine (3 x 20 mg/d)
Number of subjects: 393
Study: 7014183

Group type: EXPERIMENTAL
Intervention: Metoclopramide (Cerucal, 10 mg i.v. or p.o.)
Number of subjects: 14
Study: 31791892

Group type: EXPERIMENTAL
Intervention: Outside-In retrograde drilling (OI)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Anteromedial Portal with Flexible reamer (AMP-FR)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Transtibial (TT)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Anteromedial Portal with Rigid reamer (AMP-RR)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (intact native ACL)
Number of subjects: 72
Study: 30343563

Group type: EXPERIMENTAL
Intervention: i-gel®
Number of subjects: 0

Group type: COMPARATOR
Intervention: LMA SupremeTM
Number of subjects: 0
Study: 28509727

Group type: EXPERIMENTAL
Intervention: Calcium Channel Blockers (CCBs)
Number of subjects: 1951

Group type: EXPERIMENTAL
Intervention: Angiotensin Receptor Blockers (ARBs)
Number of subjects: 1951

Group type: EXPERIMENTAL
Intervention: Calcium Channel Blockers (CCBs) in participants without a history of cardiovascular disease
Number of subjects: 1951

Group type: EXPERIMENTAL
Intervention: Calcium Channel Blockers (CCBs) in participants with uncontrolled hypertension
Number of subjects: 1951

Group type: COMPARATOR
Intervention: Any other antihypertensive medication (Control)
Number of subjects: 1951
Study: 25272094

Group type: EXPERIMENTAL
Intervention: Pregabalin (75-600 mg/d for DPN, 150-600 mg/d for PHN)
Number of subjects: 4527

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4527
Study: 24129974

Group type: EXPERIMENTAL
Intervention: Pertuzumab, trastuzumab, and docetaxel
Number of subjects: 808

Group type: COMPARATOR
Intervention: Placebo, trastuzumab, and docetaxel
Number of subjects: 808
Study: 21704965

Group type: EXPERIMENTAL
Intervention: Difluprednate 0.05%
Number of subjects: 52

Group type: COMPARATOR
Intervention: Prednisolone acetate 1%
Number of subjects: 52
Study: 18357434

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition supplemented with fish oil (n-3/n-6 ratio of 1:2)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard parenteral nutrition (n-3/n-6 ratio of 1:7)
Number of subjects: 166
Study: 16799212

Group type: EXPERIMENTAL
Intervention: Prevention of cardiovascular disease in diabetes mellitus
Number of subjects: 8400000
Study: 14630384

Group type: EXPERIMENTAL
Intervention: Outreach training
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Training plus telephone-based support
Number of subjects: 212

Group type: COMPARATOR
Intervention: Written guidelines (controls)
Number of subjects: 212
Study: 11237545

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate head-up tilt
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Isoprenaline head-up tilt
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (healthy controls)
Number of subjects: 48
Study: 9246100

Group type: EXPERIMENTAL
Intervention: Systematic replacement of central venous catheters on a guide wire every 4 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard procedure (one-way catheters left in situ as needed)
Number of subjects: 150
Study: 8106908

Group type: EXPERIMENTAL
Intervention: Cisplatin + Etoposide (VP16) alternating with Cyclophosphamide + Epirubicin
Number of subjects: 113

Group type: COMPARATOR
Intervention: Cyclophosphamide + Epirubicin + Vincristine
Number of subjects: 113
Study: 3631561

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (2 mg/min) started 30 min before operation and continued for 24 hr after surgery (n = 18)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (2 mg/min)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Saline infusion (n = 20)
Number of subjects: 38
Study: 31980545

Group type: EXPERIMENTAL
Intervention: Prenatal surgery
Number of subjects: 161

Group type: COMPARATOR
Intervention: Postnatal surgery
Number of subjects: 161
Study: 30134358

Group type: EXPERIMENTAL
Intervention: Observed partner intimacy (female partner stressed)
Number of subjects: 366

Group type: EXPERIMENTAL
Intervention: Observed partner intimacy (male partner stressed)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Both partners stressed in parallel
Number of subjects: 366

Group type: COMPARATOR
Intervention: Only the female partner stressed
Number of subjects: 366

Group type: COMPARATOR
Intervention: Only the male partner stressed
Number of subjects: 366
Study: 28674701

Group type: EXPERIMENTAL
Intervention: Gluma desensitiser
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Pro-Relief
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Copal F
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (distilled water)
Number of subjects: 68
Study: 25413839

Group type: EXPERIMENTAL
Intervention: Sleep hygiene measures and progressive muscle relaxation techniques for 4 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 16
Study: 23182410

Group type: EXPERIMENTAL
Intervention: Contingency management (CM)
Number of subjects: 19
Study: 22099890

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine via inferior alveolar nerve block (IANB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine via buccal infiltration (B Infil)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2% lidocaine with 1:100,000 epinephrine via inferior alveolar nerve block (IANB)
Number of subjects: 0
Study: 18306855

Group type: EXPERIMENTAL
Intervention: MVE ceramide-containing liquid cleanser and moisturizing cream plus fluocinonide cream 0.05%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bar cleanser plus fluocinonide cream 0.05%
Number of subjects: 0
Study: 17181872

Group type: EXPERIMENTAL
Intervention: Increased daily water intake by 1 litre/d
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Ingested 1 litre blueberry juice/d
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (no increased fluid intake)
Number of subjects: 94
Study: 14530832

Group type: EXPERIMENTAL
Intervention: Modified Burch procedure (n=19)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sling placement (n=17)
Number of subjects: 36
Study: 11126099

Group type: EXPERIMENTAL
Intervention: Dietary changes
Number of subjects: 0
Study: 8765618

Group type: EXPERIMENTAL
Intervention: High dose RSVIG (750 mg/kg monthly)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Low dose RSVIG (150 mg/kg monthly)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Control (no RSVIG)
Number of subjects: 249
Study: 1544195

Group type: EXPERIMENTAL
Intervention: Droperidol 0.075 mg.kg-1
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Droperidol plus P6 acupuncture
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: P6 acupuncture alone
Number of subjects: 90

Group type: COMPARATOR
Intervention: Droperidol
Number of subjects: 90
Study: 2865926

Group type: EXPERIMENTAL
Intervention: Glucose-insulin-potassium (GIK) solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyaluronidase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrate derivatives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other calcium antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0
Study: 30586011

Group type: EXPERIMENTAL
Intervention: Defect-closing group (barbed suture)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 30558556

Group type: EXPERIMENTAL
Intervention: Touchscreen device
Number of subjects: 30

Group type: COMPARATOR
Intervention: Finger Motion control device
Number of subjects: 30

Group type: COMPARATOR
Intervention: Motion tracking device
Number of subjects: 30
Study: 26913407

Group type: EXPERIMENTAL
Intervention: Combined therapy group (DC-CIK + chemotherapy)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Chemotherapy group
Number of subjects: 42
Study: 25145762

Group type: EXPERIMENTAL
Intervention: Immediate removal of urinary catheter after elective cesarean section
Number of subjects: 300

Group type: COMPARATOR
Intervention: Delayed removal of urinary catheter 12 h postoperatively
Number of subjects: 300
Study: 22296865

Group type: EXPERIMENTAL
Intervention: DHEA treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 60
Study: 20726278

Group type: EXPERIMENTAL
Intervention: Bilateral electrical stimulation of the vestibular apparatus at a frequency of 0.5 Hz
Number of subjects: 198

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 198
Study: 18407311

Group type: EXPERIMENTAL
Intervention: Salient singleton color distractor present on a small proportion of trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salient singleton color distractor present on a large proportion of trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: No distractor trials
Number of subjects: 0
Study: 15812748

Group type: EXPERIMENTAL
Intervention: In-hospital initiation of carvedilol
Number of subjects: 567

Group type: COMPARATOR
Intervention: Standard practice of postdischarge beta-blocker initiation
Number of subjects: 567
Study: 12873840

Group type: EXPERIMENTAL
Intervention: Video feedback group
Number of subjects: 20

Group type: COMPARATOR
Intervention: No-feedback group
Number of subjects: 20
Study: 10328319

Group type: EXPERIMENTAL
Intervention: Workshop in palliative cancer care for general practitioners
Number of subjects: 120
Study: 7547047

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 39

Group type: COMPARATOR
Intervention: Methohexitone
Number of subjects: 39
Study: 8444273

Group type: EXPERIMENTAL
Intervention: Acipimox 250 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3018566

Group type: EXPERIMENTAL
Intervention: Captopril, 150 mg daily
Number of subjects: 42

Group type: COMPARATOR
Intervention: Enalapril, 40 mg daily
Number of subjects: 42
Study: 29984884

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive therapy (target SBP < 120 mm Hg)
Number of subjects: 8884

Group type: COMPARATOR
Intervention: Standard antihypertensive therapy (target SBP < 140 mm Hg)
Number of subjects: 8884

Group type: EXPERIMENTAL
Intervention: Both treatment arms (intensive and standard)
Number of subjects: 8884

Group type: EXPERIMENTAL
Intervention: Visit-to-visit DBP variability
Number of subjects: 8884
Study: 26318982

Group type: EXPERIMENTAL
Intervention: Monopolar transurethral prostate resection
Number of subjects: 279

Group type: COMPARATOR
Intervention: Bipolar transurethral prostate resection
Number of subjects: 279
Study: 24633589

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training at low 12 Hz frequency, 10 weeks, twice-a-week
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham training without vibration
Number of subjects: 15
Study: 23156119

Group type: EXPERIMENTAL
Intervention: NaFeEDTA-fortified wheat meal
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control meal without added iron
Number of subjects: 179
Study: 20237125

Group type: EXPERIMENTAL
Intervention: Infliximab plus methotrexate (mean dose 4.4 mg/kg per infusion, administered every 8 weeks)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Infliximab plus methotrexate
Number of subjects: 78
Study: 18294029

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave lithotripsy (SWL) using Modulith SLX Classic and Modulith SLX‐F2 lithotripters
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave lithotripsy (SWL)
Number of subjects: 598
Study: 16187871

Group type: EXPERIMENTAL
Intervention: 20 mg cortisol
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: 40 mg cortisol
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Cortisol (20 mg and 40 mg)
Number of subjects: 85
Study: 12562575

Group type: EXPERIMENTAL
Intervention: Clozapine (N=27)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Haloperidol (N=25)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Olanzapine (N=22)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Olanzapine (N=26)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Overall (N=101)
Number of subjects: 101
Study: 9442160

Group type: EXPERIMENTAL
Intervention: Sweeping of the membranes
Number of subjects: 278

Group type: COMPARATOR
Intervention: Routine pelvic examination (Control)
Number of subjects: 278
Study: 8031553

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1000 mg/day)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 2721846

Group type: EXPERIMENTAL
Intervention: Skills oriented training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sexual awareness oriented training
Number of subjects: 24
Study: 1098684

Group type: EXPERIMENTAL
Intervention: Procainamide
Number of subjects: 81

Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Overall comparison
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 81
Study: 31318997

Group type: EXPERIMENTAL
Intervention: Risk factors identified for diabetes mellitus (DM) in idiopathic chronic pancreatitis (ICP) patients: adult at onset of ICP, biliary stricture at/before diagnosis of CP, steatorrhea at/before diagnosis of CP, complex pathologic changes in main pancreatic duct.
Number of subjects: 1633

Group type: EXPERIMENTAL
Intervention: Nomogram developed based on training cohort.
Number of subjects: 1633
Study: 31383430

Group type: EXPERIMENTAL
Intervention: Manual Cranial Therapy (MC-t)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Massage Therapy (Mss-t)
Number of subjects: 50
Study: 29077724

Group type: EXPERIMENTAL
Intervention: Telephone-based aftercare case management (ACM) consisting of six phone contacts at two-week intervals by trained psychotherapists.
Number of subjects: 199

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 199
Study: 26164391

Group type: EXPERIMENTAL
Intervention: Non-adherent vegan and vegetarian participants (n=16)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Non-adherent vegan/vegetarian participants (n=16)
Number of subjects: 38

Group type: COMPARATOR
Intervention: All diet groups (vegan, vegetarian, pesco-vegetarian, semi-vegetarian, omnivore)
Number of subjects: 38
Study: 23187069

Group type: EXPERIMENTAL
Intervention: Group psychological intervention based on cognitive behavioral therapy and motivational interviewing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 21999295

Group type: EXPERIMENTAL
Intervention: Exercise at self‐selected intensity, expending 700 kcal per session for men and 500 kcal per session for women
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Exercise intensity
Number of subjects: 34